InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Bruce Booth, Director, is a corporate insider tracked by InsiderTape across 3 companies. The public record shows 48 open-market SEC Form 4 transactions: 2 purchases worth $8.6M and 46 sales worth $154.8M, reported from Aug 11, 21 to Jun 29, 26. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 29, 26 | KYMRKymera Therapeutics, Inc. | SELL | 19.4K | $111.20 | $2.1M |
| Jun 26, 26 | KYMRKymera Therapeutics, Inc. | SELL | 231.0K | $118.66 | $25.0M |
| Jun 25, 26 | KYMRKymera Therapeutics, Inc. | SELL | 112.3K | $129.61 | $13.5M |
| Jun 24, 26 | KYMRKymera Therapeutics, Inc. | SELL | 103.7K | $101.14 | $10.4M |
| Jun 23, 26 | KYMRKymera Therapeutics, Inc. | SELL | 1.2K | $99.98 | $123K |
| Jun 22, 26 | KYMRKymera Therapeutics, Inc. | SELL | 56.3K | $104.38 | $5.6M |
| Jun 18, 26 | KYMRKymera Therapeutics, Inc. | SELL | 62.9K | $92.16 | $5.7M |
| Jun 17, 26 | KYMRKymera Therapeutics, Inc. | SELL | 92.2K | $90.38 | $8.3M |
| Apr 22, 26 | KYMRKymera Therapeutics, Inc. | SELL | 5.9K | $90.08 | $531K |
| Apr 15, 26 | KYMRKymera Therapeutics, Inc. | SELL | 2.8K | $90.10 | $248K |
| Apr 14, 26 | KYMRKymera Therapeutics, Inc. | SELL | 4.2K | $89.97 | $374K |
| Mar 2, 26 | KYMRKymera Therapeutics, Inc. | SELL | 71.8K | $90.13 | $6.5M |
| Dec 12, 25 | KYMRKymera Therapeutics, Inc. | SELL | 570 | $91.04 | $52K |
| Dec 11, 25 | KYMRKymera Therapeutics, Inc. | SELL | 5.1K | $91.23 | $468K |
| Dec 10, 25 | KYMRKymera Therapeutics, Inc. | SELL | 85.9K | $93.20 | $8.0M |
| Oct 21, 25 | SIONSionna Therapeutics, Inc. | SELL | 25.3K | $36.42 | $904K |
| Oct 20, 25 | SIONSionna Therapeutics, Inc. | SELL | 25.8K | $32.33 | $834K |
| Oct 17, 25 | SIONSionna Therapeutics, Inc. | SELL | 28.8K | $33.47 | $925K |
| Oct 16, 25 | SIONSionna Therapeutics, Inc. | SELL | 73.3K | $33.38 | $2.4M |
| Oct 15, 25 | SIONSionna Therapeutics, Inc. | SELL | 65.7K | $31.12 | $2.0M |
| Oct 14, 25 | SIONSionna Therapeutics, Inc. | SELL | 501 | $29.95 | $15K |
| Oct 13, 25 | SIONSionna Therapeutics, Inc. | SELL | 44.0K | $31.03 | $1.3M |
| Oct 10, 25 | SIONSionna Therapeutics, Inc. | SELL | 16.7K | $29.98 | $501K |
| Oct 6, 25 | SIONSionna Therapeutics, Inc. | SELL | 9.8K | $29.95 | $292K |
| Oct 3, 25 | SIONSionna Therapeutics, Inc. | SELL | 31.2K | $30.00 | $936K |
| Oct 1, 25 | SIONSionna Therapeutics, Inc. | SELL | 165 | $29.95 | $5K |
| Sep 30, 25 | SIONSionna Therapeutics, Inc. | SELL | 10.2K | $30.06 | $308K |
| Sep 29, 25 | SIONSionna Therapeutics, Inc. | SELL | 54.6K | $30.09 | $1.6M |
| Feb 10, 25 | SIONSionna Therapeutics, Inc. | BUY | 60.0K | $18.00 | $1.1M |
| Jul 9, 24 | KYMRKymera Therapeutics, Inc. | SELL | 183.9K | $39.26 | $7.1M |
| Jun 13, 24 | KYMRKymera Therapeutics, Inc. | SELL | 8.4K | $34.98 | $295K |
| Jun 12, 24 | KYMRKymera Therapeutics, Inc. | SELL | 11.8K | $36.02 | $418K |
| Mar 15, 24 | KYMRKymera Therapeutics, Inc. | SELL | 49.6K | $41.23 | $2.0M |
| Mar 14, 24 | KYMRKymera Therapeutics, Inc. | SELL | 34.5K | $41.51 | $1.4M |
| Mar 13, 24 | KYMRKymera Therapeutics, Inc. | SELL | 108.4K | $42.84 | $4.6M |
| Mar 12, 24 | KYMRKymera Therapeutics, Inc. | SELL | 126.1K | $42.52 | $5.3M |
| Mar 11, 24 | KYMRKymera Therapeutics, Inc. | SELL | 37.2K | $43.42 | $1.6M |
| Jan 12, 23 | KYMRKymera Therapeutics, Inc. | SELL | 77.1K | $30.29 | $2.3M |
| Jan 11, 23 | KYMRKymera Therapeutics, Inc. | SELL | 21.7K | $29.96 | $650K |
| Dec 15, 22 | KYMRKymera Therapeutics, Inc. | SELL | 2.6K | $30.00 | $77K |
| Dec 14, 22 | KYMRKymera Therapeutics, Inc. | SELL | 112.8K | $34.02 | $3.4M |
| Nov 3, 22 | KYMRKymera Therapeutics, Inc. | SELL | 75.3K | $30.00 | $2.3M |
| Nov 2, 22 | KYMRKymera Therapeutics, Inc. | SELL | 96.6K | $30.02 | $2.9M |
| Nov 1, 22 | KYMRKymera Therapeutics, Inc. | SELL | 56.5K | $31.08 | $1.7M |
| Oct 31, 22 | KYMRKymera Therapeutics, Inc. | SELL | 94.2K | $30.23 | $2.8M |
| Oct 28, 22 | KYMRKymera Therapeutics, Inc. | SELL | 71.1K | $30.00 | $2.1M |
| Jan 11, 22 | VIGLVigil Neuroscience, Inc. | BUY | 535.0K | $14.00 | $7.5M |
| Aug 11, 21 | KYMRKymera Therapeutics, Inc. | SELL | 242.1K | $61.00 | $14.8M |